Stocks News

LAST PRICE
9.6400
TODAY'S CHANGE (%)
Trending Down-0.4000 (-3.9841%)

Bid / Lots
9.5000/ 30
Ask / Lots
9.9300/ 10
Open / Previous Close
10.0800 / 10.0400
Day Range
Low 9.5235
High 10.1600
52 Week Range
Low 6.4300
High 11.9000
Volume
793,681
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- DJ AdaptHealth Is Maintained at Buy by Truist Securities, from 10 hours ago by Dow Jones
  10 hours ago by Dow Jones
  Companies Mentioned: AHCO
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/AHCO/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 15, 2024 10:24 ET (15:24 GMT)
- Truist Lowers Price Target on AdaptHealth to $12 From $13, Maintains Buy Rating, from 13 hours ago by MT Newswires
  13 hours ago by MT Newswires
  Companies Mentioned: AHCO
  07:35 AM EST, 11/15/2024 (MT Newswires) -- AdaptHealth (AHCO) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $9 to $14. (MT Newswires covers equity, commodity and economic research...
Nov 12, 2024
- AdaptHealth Corp. to Participate in the Stifel 2024 Healthcare Conference, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
  4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: AHCO
  
  AdaptHealth Corp. to Participate in the Stifel 2024 Healthcare Conference
  PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--November 12, 2024--
  AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the Stifel 2024 Healthcare Conference, being held in New York, NY, on Tuesday, November 19, 2024, including a fireside chat at 8:00am ET. The webcast link will be available on the Company's website, www.adapthealth.com under "Investor Relations."
Nov 6, 2024
- DJ AdaptHealth Is Maintained at Buy by UBS, from 2:17PM ET on Wednesday Nov 06, 2024 by Dow Jones
  2:17PM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: AHCO
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/AHCO/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 06, 2024 14:17 ET (19:17 GMT)
- DJ AdaptHealth Is Maintained at Buy by Canaccord Genuity, from 12:57PM ET on Wednesday Nov 06, 2024 by Dow Jones
  12:57PM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: AHCO
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/AHCO/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 06, 2024 12:57 ET (17:57 GMT)

Today
- Myriad Genetics, Inc. (MYGN) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates, from 10 hours ago by Dow Jones
  10 hours ago by Dow Jones
  Companies Mentioned: MYGN
- Bronstein, Gewirtz & Grossman, LLC Encourages Myriad Genetics, Inc. (MYGN) Shareholders to Inquire about Securities Investigation, from 11 hours ago by Dow Jones
  11 hours ago by Dow Jones
  Companies Mentioned: MYGN
Yesterday
- Myriad Genetics, Inc. Being Investigated on Behalf of Myriad Genetics, Inc. Investors. Contact Levi & Korsinsky For Details, from 10:31AM ET on Thursday Nov 14, 2024 by Dow Jones
  10:31AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: MYGN
- Bronstein, Gewirtz & Grossman, LLC Is Investigating Myriad Genetics, Inc. (MYGN) And Encourages Shareholders to Connect, from 10:01AM ET on Thursday Nov 14, 2024 by Dow Jones
  10:01AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: MYGN
Nov 13, 2024
- Shareholders that Lost Money on Myriad Genetics, Inc. (MYGN) Should Contact Levi & Korsinsky about Securities Fraud Investigation - MYGN, from 4:46PM ET on Wednesday Nov 13, 2024 by Dow Jones
  4:46PM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: MYGN
- Integra's DuraSeal(R) Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research, from 4:10PM ET on Wednesday Nov 13, 2024 by Dow Jones
  4:10PM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: IART
- MYGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Myriad Genetics, Inc. and Encourages Investors to Contact the Firm, from 4:00PM ET on Wednesday Nov 13, 2024 by Dow Jones
  4:00PM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: MYGN
- Did Myriad Genetics, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - MYGN, from 10:16AM ET on Wednesday Nov 13, 2024 by Dow Jones
  10:16AM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: MYGN
- Myriad Genetics Says Fetal Gender Test Available at Over 8,000 Stores in US, from 10:07AM ET on Wednesday Nov 13, 2024 by MT Newswires
  10:07AM ET on Wednesday Nov 13, 2024 by MT Newswires
  Companies Mentioned: MYGN, WBA, WMT, CVS
- Bronstein, Gewirtz & Grossman, LLC Is Investigating Myriad Genetics, Inc. (MYGN) And Encourages Investors to Connect, from 10:02AM ET on Wednesday Nov 13, 2024 by Dow Jones
  10:02AM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: MYGN

Adapthealth Corp
NASDAQ:AHCOUnited States

Search Criteria

Today

DJ AdaptHealth Is Maintained at Buy by Truist Securities, from 10 hours ago by Dow Jones

Truist Lowers Price Target on AdaptHealth to $12 From $13, Maintains Buy Rating, from 13 hours ago by MT Newswires

Nov 12, 2024

AdaptHealth Corp. to Participate in the Stifel 2024 Healthcare Conference, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones

Nov 6, 2024

DJ AdaptHealth Is Maintained at Buy by UBS, from 2:17PM ET on Wednesday Nov 06, 2024 by Dow Jones

DJ AdaptHealth Is Maintained at Buy by Canaccord Genuity, from 12:57PM ET on Wednesday Nov 06, 2024 by Dow Jones

Peers Headlines

Today

Myriad Genetics, Inc. (MYGN) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates, from 10 hours ago by Dow Jones

Bronstein, Gewirtz & Grossman, LLC Encourages Myriad Genetics, Inc. (MYGN) Shareholders to Inquire about Securities Investigation, from 11 hours ago by Dow Jones

Yesterday

Myriad Genetics, Inc. Being Investigated on Behalf of Myriad Genetics, Inc. Investors. Contact Levi & Korsinsky For Details, from 10:31AM ET on Thursday Nov 14, 2024 by Dow Jones

Bronstein, Gewirtz & Grossman, LLC Is Investigating Myriad Genetics, Inc. (MYGN) And Encourages Shareholders to Connect, from 10:01AM ET on Thursday Nov 14, 2024 by Dow Jones

Nov 13, 2024

Shareholders that Lost Money on Myriad Genetics, Inc. (MYGN) Should Contact Levi & Korsinsky about Securities Fraud Investigation - MYGN, from 4:46PM ET on Wednesday Nov 13, 2024 by Dow Jones

Integra's DuraSeal(R) Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research, from 4:10PM ET on Wednesday Nov 13, 2024 by Dow Jones

MYGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Myriad Genetics, Inc. and Encourages Investors to Contact the Firm, from 4:00PM ET on Wednesday Nov 13, 2024 by Dow Jones

Did Myriad Genetics, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - MYGN, from 10:16AM ET on Wednesday Nov 13, 2024 by Dow Jones

Myriad Genetics Says Fetal Gender Test Available at Over 8,000 Stores in US, from 10:07AM ET on Wednesday Nov 13, 2024 by MT Newswires

Bronstein, Gewirtz & Grossman, LLC Is Investigating Myriad Genetics, Inc. (MYGN) And Encourages Investors to Connect, from 10:02AM ET on Wednesday Nov 13, 2024 by Dow Jones